Novartis India's Stock Hits 52-Week High, Outperforms Sector with Strong Performance

Feb 19 2024 09:35 AM IST
share
Share Via
Novartis India, a smallcap pharmaceutical company, has seen a 52-week high on February 19, 2024. With a rise of 24.6% in the last 5 days and currently trading above its moving averages, the stock is rated as 'Hold' by MarketsMojo. It also offers a high dividend yield of 4.59%.

Novartis India, a smallcap pharmaceutical company, has recently hit a 52-week high on February 19, 2024. The stock has been performing well and has been gaining for the last 5 days, with a rise of 24.6% in this period. It opened with a gain of 7.58% today and touched an intraday high of Rs 1148, outperforming the sector by 6.88%.

According to MarketsMOJO, a leading stock analysis platform, the stock is currently rated as 'Hold'. It has also been identified as part of the Hidden Turnaround category on MarketsMOJO since January 25, 2024.

Novartis India is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance. It also offers a high dividend yield of 4.59% at the current price.

In the past year, Novartis India has shown a strong performance with a 86.93% increase in its stock price, while the Sensex has only seen a growth of 18.87%. This showcases the company's potential and growth in the pharmaceutical industry.

Novartis India is a smallcap company in the pharma industry, and its recent surge in stock price and positive performance indicators make it an attractive option for investors. However, it is important to do thorough research and consult with a financial advisor before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Novartis India falling/rising?
Dec 05 2025 12:56 AM IST
share
Share Via
Why is Novartis India falling/rising?
Nov 06 2025 10:05 PM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 05 2025 08:06 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 03 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 02 2025 08:04 AM IST
share
Share Via